2791 — Daikokutenbussan Balance Sheet
0.000.00%
- ¥51bn
- ¥78bn
- ¥319bn
Annual balance sheet for Daikokutenbussan, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | 2026 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9,540 | 8,630 | 12,023 | 8,488 | 10,337 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | -80 | -52 | -58 | 154 | 156 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 21,160 | 23,890 | 25,835 | 25,200 | 30,383 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 47,878 | 59,892 | 64,381 | 76,602 | 93,588 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 81,930 | 97,194 | 104,352 | 116,403 | 139,295 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 26,273 | 30,703 | 35,941 | 46,190 | 48,977 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 35,232 | 47,784 | 48,969 | 55,456 | 78,204 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 46,698 | 49,410 | 55,383 | 60,947 | 61,091 |
| Total Liabilities & Shareholders' Equity | 81,930 | 97,194 | 104,352 | 116,403 | 139,295 |
| Total Common Shares Outstanding |